NCT04627740 2026-01-20
Anti-ALPP CAR-T Cells Immunotherapy for Advanced Solid Tumors
Xinqiao Hospital of Chongqing
Phase 1/2 Completed
Clinical Trials
47 trialsNCT02065726 2025-05-01
Whey Protein Supplementation in Cancer Patients
Fondazione IRCCS Policlinico San Matteo di Pavia
Phase NA Completed
NCT02506517 2023-08-01
A Study of Afatinib in Patients With Advanced Cancer With Changes in the HER Gene
University Health Network, Toronto
Phase 2 Completed
NCT02426892 2023-04-18
Nivolumab and HPV-16 Vaccination in Patients With HPV-16 Positive Incurable Solid Tumors
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01379287 2023-02-02
Dose-Escalation Safety and Pharmacokinetic Study of Iso-Fludelone in Patients With Advanced Solid Tumors
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT02303028 2022-06-28
TOPAZ
The Hospital for Sick Children
Phase 1/2 Completed
NCT00613847 2020-10-26
Biodistribution and Dosimetry of Serial PET Imaging With Ga-68 Labeled F(ab') 2- Trastuzumab
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT02078349 2020-09-10
Phase I Study of KPT330 in Asian Patients
National University Hospital, Singapore
Phase 1 Completed
NCT02135510 2020-03-31
MEDEA
Amsterdam UMC, location VUmc
Phase 3 Completed
NCT01345513 2020-03-23
Feasibility Clinical Study of Targeted and Genome-Wide Sequencing
University Health Network, Toronto
Completed
NCT02058901 2019-07-17
Study of High-dose, Intermittent Sunitinib in Patients With Solid Tumors.
Amsterdam UMC, location VUmc
Phase 1 Completed
NCT02250781 2019-05-22
Oral ONC201 in Treating Patients With Advanced Solid Tumors
Rutgers, The State University of New Jersey
Phase 1 Completed
NCT01949688 2019-03-19
Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*24 or A*02-positive Advanced Solid Tumors
Shiga University
Phase 1/2 Completed
NCT02157831 2018-08-17
Redosing With CP-870, 893 in Patients With Clinical Benefit After a Single Infusion From A Phase I, Open-Label, Dose-Escalation Study of CP-870,893 in Patients With Solid Tumors
Abramson Cancer Center at Penn Medicine
Phase EARLY_PHASE1 Completed
NCT02439489 2018-06-20
Study of the Combination of BKM120 and Cisplatin or Carboplatin in Patients With Advanced Solid Tumors
Fondazione Michelangelo
Phase 1 Completed
NCT02619045 2018-03-02
EVAL'COACH
Institut Claudius Regaud
Phase NA Completed
NCT02296879 2018-01-17
A Multicenter, Open Label, Phase I Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Intravenous SAIT301 in Subjects With Advanced c-MET Positive (+) Solid Tumors Followed by Expansion in Selected Tumor Types
Samsung Medical Center
Phase 1 Completed
NCT01485042 2017-09-01
PATH
Duke University
Phase 1 Completed
NCT00776867 2017-08-01
Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT00186979 2017-04-26
Study of ZD1839 Combined With Irinotecan and Vincristine in Pediatric Patients With Refractory Solid Tumors
St. Jude Children's Research Hospital
Phase 1 Completed
NCT01297452 2017-03-31
BKM120 + Carboplatin + Paclitaxel for Patients With Advanced Solid Tumors
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT02353026 2016-11-18
Phase I Study of Intravenous Artesunate for Solid Tumors
Georgetown University
Phase 1 Completed
NCT01349296 2016-05-20
BARIS
University of Cologne
Phase 1 Completed
NCT00554268 2016-02-19
Trial of PBI-05204 in Advanced Cancer Patients
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00770263 2015-06-03
Erlotinib and Temsirolimus for Solid Tumors
Washington University School of Medicine
Phase 1 Completed
NCT00888043 2015-03-11
CNTO95/Avastin
Duke University
Phase 1 Completed
NCT00984425 2014-12-02
The Treatment of Lapatinib in Combination With Sorafenib in Patients With Advanced Refractory Solid Tumors
Istituto Clinico Humanitas
Phase 1 Completed
NCT00586443 2014-11-19
BEP
Duke University
Phase 1 Completed
NCT01702129 2014-09-09
Anti-EGFR Immunoliposomes in Solid Tumors
University Hospital, Basel, Switzerland
Phase 1 Completed
NCT00720148 2014-08-26
A Phase I Trial of Bortezomib and Sunitinib
Emory University
Phase 1 Completed
NCT00697437 2013-12-10
Effect of Ketoconazole Inhibition of CYP3A on Urinary Excretion of Docetaxel
National University Hospital, Singapore
Phase 2 Completed
NCT00869388 2013-07-15
A Phase I Study of Bi-Weekly rBBX-01 in Patients With Solid Tumors
Washington University School of Medicine
Phase 1 Completed
NCT00583063 2013-06-12
Interaction Study of Rapamycin and Sunitinib in Patients With Advanced Cancers
University of Chicago
Phase EARLY_PHASE1 Completed
NCT00586092 2013-04-08
A Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid Tumors
Duke University
Phase 1 Completed
NCT01800812 2013-02-28
OM-174
Centre Hospitalier Universitaire Dijon
Phase 1 Completed
NCT00500422 2013-02-13
Doxil, Gemcitabine, and Velcade (PS341) in Advanced Cancer Patients
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00601133 2013-01-10
Function and Balance for Inpatient Rehabilitation
M.D. Anderson Cancer Center
Completed
NCT00697502 2012-11-01
Study of Capecitabine In Patients With Solid Tumors
National University Hospital, Singapore
Phase 1 Completed
NCT00495872 2012-10-18
Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid Tumor
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00502892 2012-08-01
Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00509782 2012-08-01
Phase I Trial of ZIO-101 in Patients With Solid Tumors
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00586560 2012-05-15
KTN10010
Baylor College of Medicine
Phase 1 Completed
NCT00703378 2012-03-28
Target Dosing of Docetaxel Through Pharmacokinetic/Pharmacodynamic Optimisation of the First Chemotherapeutic Cycle
National University Hospital, Singapore
Phase 1/2 Completed
NCT01072890 2012-03-28
Temsirolimus and Pazopanib in Patients With Advanced Solid Tumors
University of California, Davis
Phase 1 Completed
NCT00556088 2010-12-30
LBH589, Paclitaxel, Carboplatin +/- Bevacizumab for Solid Tumors
SCRI Development Innovations, LLC
Phase 1 Completed
NCT00863733 2009-03-18
DMXAA
Cancer Research UK
Phase 1 Completed
NCT00628732 2009-01-28
A Pharmacokinetic Study of Oral Cyclophosphamide and Topotecan in Children With Recurrent Solid Tumors
Children's Medical Center Dallas
Phase 2 Completed